Cargando…
Current Advances in Retroviral Gene Therapy
There have been major changes since the incidents of leukemia development in X-SCID patients after the treatments using retroviral gene therapy. Due to the risk of oncogenesis caused by retroviral insertional activation of host genes, most of the efforts focused on the lentiviral therapies. However,...
Autores principales: | Yi, Youngsuk, Jong Noh, Moon, Hee Lee, Kwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182074/ https://www.ncbi.nlm.nih.gov/pubmed/21453283 http://dx.doi.org/10.2174/156652311795684740 |
Ejemplares similares
-
Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives
por: Vargas, José Eduardo, et al.
Publicado: (2016) -
Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients
por: Ha, Chul-Won, et al.
Publicado: (2012) -
Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges
por: Yoder, Kristine E., et al.
Publicado: (2021) -
Retroviral Integrations in Gene Therapy Trials
por: Biasco, Luca, et al.
Publicado: (2012) -
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery
por: Anson, Donald S
Publicado: (2004)